How often it was reported
Abdominal pain figures come from several trial groups. Adults with type 2 diabetes in the placebo-controlled pool, SURPASS-1 and SURPASS-5, supply the US label’s Table 1 [1]. Children and teenagers aged 10 and older come from SURPASS-PEDS, compared with placebo for 30 weeks. Adults with established heart disease come from SURPASS-CVOT, where 10% of 6,647 people on Mounjaro® reported abdominal pain; the comparison was dulaglutide, for which no figure is printed [1]. Canada adds a seven-trial pool of 5,119 people on tirzepatide [4].
| Trial group | Placebo | 5 mg | 10 mg | 15 mg |
|---|---|---|---|---|
| US: adult placebo-controlled pool [1] | 4% | 6% | 5% | 5% |
| Canada: same pool, unrounded [4] | 4.3% | 5.9% | 4.6% | 5.4% |
| Canada: 7 phase 3 trials [4] | No placebo column | 7.2% | 8.0% | 9.9% |
| US: ages 10 and older, first 30 weeks [1] | 9% | 22% | 15% | Not studied |
Adults: near placebo in short trials, higher elsewhere
In the short placebo-controlled trials, the difference from placebo is small and does not rise with dose [1]. A meta-analysis of tirzepatide trials in type 2 diabetes reached the same conclusion: abdominal pain and abdominal distension were comparable with placebo, unlike nausea, vomiting, constipation and decreased appetite [5]. Abdominal pain still met the bar for the US table, which lists reactions seen in at least 5% of people on the medicine and more often than on placebo, and the Medication Guide counts stomach pain among the most common side effects [1][2].
Other data sets show more. In the Canadian seven-trial pool, abdominal pain climbed from 7.2% on 5 mg to 9.9% on 15 mg [4]. SURPASS-CVOT, with older adults followed for about four years, reported 10% [1]. The European information rates abdominal pain as “very common”, at least 1 in 10, in its weight-management, heart, sleep apnoea, heart failure and pediatric trials, and “common” in adult diabetes trials [3].
Children
In SURPASS-PEDS, 97 young people with an average age of 15 received Mounjaro® 5 mg or 10 mg. The US label says their reactions resembled those of adults except that vomiting, abdominal pain and low blood sugar were more frequent, and gives no reason [1]. During the placebo-controlled period, abdominal pain affected 22% on 5 mg and 15% on 10 mg, against 9% on placebo [1]. The European information reports the same three exceptions [3]. A child with stomach pain also needs the same warning signs checked as an adult.
Why tirzepatide can cause stomach pain
What the labels support: tirzepatide delays stomach emptying, most strongly after the first dose, and causes a group of stomach and bowel reactions that, taken together, were reported by 37.1% to 43.6% of adults on Mounjaro® against 20.4% on placebo [1]. Bloating, wind, constipation and indigestion are among them, and each can be felt as pain [1][4].
General background: MedlinePlus explains that cramp-like pain is usually due to gas and bloating, often followed by diarrhea, while pain that comes in waves, starting and stopping suddenly, is typical of gallstones and kidney stones [8]. It also warns that the strength of the pain does not always match how serious the cause is [8].
What is reported but rare: one published case described ischaemia of the colon, reduced blood flow to the large bowel, in a 62-year-old woman using tirzepatide for weight loss [7]. A single case cannot show that the medicine caused it.
Pain the labels treat as a warning sign
- Pancreatitis: persistent or severe abdominal pain, sometimes spreading to the back, with or without nausea or vomiting. The US label asks for Mounjaro® to be stopped if pancreatitis is suspected, and Europe and Canada add that it should not be restarted if confirmed [1][3][4].
- Gallbladder disease: in the adult placebo-controlled trials, 0.6% of people on Mounjaro® had acute gallbladder events against 0% on placebo [1]. The Medication Guide lists upper stomach pain, fever, yellowing and clay-coloured stools; Canada adds sudden, intensifying pain that can be felt between the shoulder blades or in the right shoulder [2][4].
- Severe stomach and bowel reactions: reported in 0.4% to 1.3% of adults on Mounjaro®, depending on dose, against 0.9% on placebo [1].
- Ileus and gastroparesis: Canada’s patient information describes ileus as bloating and pain with severe nausea and vomiting and an inability to eat, and gastroparesis as pain with severe nausea and vomiting, prolonged belching and bloating [4]. The US label lists ileus and intestinal obstruction among reports after approval [1].
What real-world data add, and other causes
In a large US cohort of adults with type 2 diabetes starting tirzepatide, semaglutide or dulaglutide, a combined outcome of serious stomach and bowel events, including pancreatitis, gallbladder disease, bowel obstruction, gastroparesis and severe constipation, occurred at similar rates on all three [6]. Observational data like this cannot rule out every difference between groups.
Belly pain has many causes unrelated to Mounjaro®. MedlinePlus lists constipation, irritable bowel syndrome, food intolerance, food poisoning and stomach flu among the less serious ones, and appendicitis, bowel blockage, diverticulitis, kidney stones, ulcers, urinary infections, hernias, endometriosis and ectopic pregnancy among others [8]. Pain felt in more than half the belly is more typical of a virus, indigestion or gas, while pain in one spot points more often to a single organ such as the appendix or gallbladder [8].
What may help with mild pain
For mild pain without warning signs, MedlinePlus suggests a few home steps, and asks you not to take any medicine for it without talking to your provider first [8]:
- Sip water or other clear fluids; MedlinePlus adds that people with diabetes need to check their blood sugar often while unwell and adjust medicines as their provider has advised [8].
- Give your stomach a short rest from solid food; after vomiting, start again with small amounts of mild foods such as rice, apple sauce or crackers, and skip dairy for a while [8].
- If pain is high up and follows meals, avoid citrus, fatty or fried food, tomato products, caffeine, alcohol and fizzy drinks [8].
- To prevent some pain, eat smaller meals more often, keep active, limit foods that give you gas, and keep meals balanced with fruit and vegetables [8].
- Because tirzepatide slows stomach emptying and can change how tablets are absorbed, ask your pharmacist before adding antacids or painkillers [1].
Describing pain so it can be assessed
The warning signs above differ in a few details, so note them each time: where the pain sits, whether it moves into the back or shoulder, whether it is constant or comes in waves, how strong it is, and whether it comes with vomiting, fever, yellowing of the skin or eyes, or pale stools. Note how it relates to meals and to your injection day. This helps your clinician tell ordinary discomfort from something that needs prompt attention; it does not replace a call when pain is severe.
Mounjaro® is a registered trademark of Eli Lilly and Company. PepLabo is not affiliated with or endorsed by Eli Lilly and Company.
When to get help
| Sign | Who to contact | How fast | Source |
|---|---|---|---|
| Severe stomach pain that will not stop, with or without vomiting, sometimes reaching the back | Stop Mounjaro® and call your healthcare provider right away | Emergency | Medication Guide [2] |
| Sudden sharp pain, a rigid or very tender belly, or being unable to pass stool while vomiting | Emergency services or the emergency room | Emergency | MedlinePlus [8] |
| Blood in vomit or stool, or chest, neck or shoulder pain with belly pain | Emergency services | Emergency | MedlinePlus [8] |
| Severe abdominal pain, yellowing of the skin, or a high fever with chills | Stop Mounjaro® and get immediate medical help | Emergency | Canadian patient information [4] |
| Pain not better within 24 to 48 hours, getting worse with nausea and vomiting, or no food or fluid kept down | Your provider | Today | MedlinePlus [8] |
| Abdominal discomfort lasting a week or more, or bloating for more than 2 days | Your provider | At your next appointment | MedlinePlus [8] |
